ReproCELL Incorporated Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ReproCELL Incorporated
Access all reports
ReproCELL Incorporated is a biotechnology company focused on advancing stem cell research and drug discovery. The company specializes in providing services and products for stem cell research, including iPSC-derived cell lines, media, and other culture reagents. It also offers predictive drug discovery services utilizing human tissues. ReproCELL's offerings support both preclinical and clinical research, with services tailored to meet regulatory standards across various global markets. Its portfolio includes advanced solutions for gene editing, stem cell therapy, and 3D cell culture systems, which cater to a wide range of scientific and medical applications. The company is headquartered in Yokohama, Kanagawa, Japan, and its shares are listed on the Tokyo Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
4978
Country
🇯🇵 Japan